Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 703 filings

Top spenders & firms Spend by issue Political contributions Revolving door

Clear
Q1
CHECKMATE GOVERNMENT RELATIONS for BIOHAVEN LTD.
1st Quarter (Jan 1 - Mar 31) 2026 · Connecticut · $80,000.00 income
Medical/Disease Research/Clinical Labs, Pharmacy, Health Issues
View →
Q1
ZIMMER BIOMET, INC. for ZIMMER BIOMET, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Medicare/Medicaid, Trade (domestic/foreign), Taxation/Internal Revenue Code, Chemicals/Chemical Industry
View →
Q1
SHIONOGI INC. for SHIONOGI INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate
Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs, Insurance
View →
Q1
CAPITOL COUNSEL LLC for MADRIGAL PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid
View →
Q1
THORN RUN PARTNERS for PHYSICIAN-LED HEALTHCARE FOR AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $10,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs
View →
Q1
TIBER CREEK GROUP for JAZZ PHARMACEUTICALS
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs, Budget/Appropriations
View →
Q1
HANCE SCARBOROUGH for HEALTHCARE ALLIANCE FOR PATIENT SAFETY (HCAPS)
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $50,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Budget/Appropriations
View →
Q1
THORN RUN PARTNERS for CONTINUING MEDICAL EDUCATION COALITION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $80,000.00 income
Medical/Disease Research/Clinical Labs
View →
Q1
CLARK HILL PUBLIC STRATEGIES LLC for GIFT OF HOPE COMMUNITY FOUNDATION
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $40,000.00 income
Health Issues, Insurance, Medical/Disease Research/Clinical Labs
View →
Q1
CLARK HILL PUBLIC STRATEGIES LLC for WEST PHARMACEUTICAL SERVICES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $50,000.00 income
Medical/Disease Research/Clinical Labs, Tariff (miscellaneous tariff bills), Trade (domestic/foreign)
View →
Q1
WINNING STRATEGIES WASHINGTON for SPINAL STABILIZATION TECHNOLOGIES, LTD
1st Quarter (Jan 1 - Mar 31) 2026 · Colorado · House · Senate · $20,000.00 income
Defense, Health Issues, Medical/Disease Research/Clinical Labs, Budget/Appropriations
View →
Q1
INDIANA UNIVERSITY for INDIANA UNIVERSITY
1st Quarter (Jan 1 - Mar 31) 2026 · Indiana · House · Senate
Government Issues, Health Issues, Intelligence, Medical/Disease Research/Clinical Labs
View →
Q1
W STRATEGIES, LLC for ALVEO TECHNOLOGIES
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate
Medical/Disease Research/Clinical Labs
View →
Q1
CONTINENTAL STRATEGY, LLC for DEXCOM
1st Quarter (Jan 1 - Mar 31) 2026 · California · $75,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs
View →
Q1
CONTINENTAL STRATEGY, LLC for MEDICAL MICRO INSTRUMENTS (MMI, INC.)
1st Quarter (Jan 1 - Mar 31) 2026 · Florida · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs
View →
Q1
THE UNIVERSITY OF FLORIDA BOARD OF TRUSTEES for THE UNIVERSITY OF FLORIDA BOARD OF TRUSTEES
1st Quarter (Jan 1 - Mar 31) 2026 · Florida · House · Senate
Small Business, Taxation/Internal Revenue Code, Budget/Appropriations, Defense
View →
Q1
WINNING STRATEGIES WASHINGTON for I AM ALS
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $10,000.00 income
Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs
View →
Q1
WINNING STRATEGIES WASHINGTON for DIABETES PATIENT ADVOCACY COALITION
1st Quarter (Jan 1 - Mar 31) 2026 · Kentucky · House · Senate · $20,000.00 income
Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q1
TWENTY-FIRST CENTURY GROUP, INC. for NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX)
1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate · $24,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs, Veterans, Budget/Appropriations
View →
Q1
CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Manufacturing, Small Business
View →
Q1
BURRELL INTERNATIONAL GROUP LLC for OXYGENIUM INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate
Medical/Disease Research/Clinical Labs
View →
Q1
CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. for CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Wisconsin · House · Senate
Budget/Appropriations, Medicare/Medicaid, Pharmacy, Health Issues
View →
Q1
CHECKMATE GOVERNMENT RELATIONS for NEPHRON NITRILE D/B/A AMERICAN ARMOR GLOVES
1st Quarter (Jan 1 - Mar 31) 2026 · South Carolina · $50,000.00 income
Defense, Medical/Disease Research/Clinical Labs
View →
Q1
AGIOS PHARMACEUTICALS for AGIOS PHARMACEUTICALS
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q1
FORBES-TATE for COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Agriculture, Banking, Financial Institutions/Investments/Securities, Government Issues
View →
Previous Page 22 of 29 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem